Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Feb
18
2016
Federal Circuit Rules Its Precedents on Domestic and International Patent Exhaustion Principles Not Changed by Supreme Court Cases McDermott Will & Emery
Feb
18
2016
Federal Circuit Sanctions PTO’s Authority To Institute IPR On A Claim-By-Claim Basis in Synopsis v. Mentor Graphics Foley & Lardner LLP
Feb
18
2016
PTO Litigation Center Report – February 18, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Feb
18
2016
Sandoz Asks Supreme Court To Reverse Biosimilar Decision Foley & Lardner LLP
Feb
17
2016
Wireless Media Innovations v. Maher Terminals, LLC, Global Terminal & Container Services, LLC: Fed. Cir., February 8, 2016 Schwegman, Lundberg & Woessner, P.A.
Feb
17
2016
On Appeal, No Fee Shifting Credit for LevelUp Proskauer Rose LLP
Feb
17
2016
Patent Dispute Over Unmanned Aerial Vehicles Launched in Northern District of Georgia Womble Bond Dickinson (US) LLP
Feb
17
2016
PTO Litigation Center Report – February 17, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Feb
16
2016
Tietex International v. Precision Fabrics Group: Petition Denied Under Board’s Discretion IPR2015-01671 Faegre Drinker
Feb
16
2016
Federal Circuit Declines to Disturb Established Precedent Regarding the Exhaustion of Patent Rights Mintz
Feb
16
2016
BMC Medical, 3B Products, and 3B Medical v. ResMed: Final Written Decision Finding Some Claims Unpatentable IPR2014-01363 Faegre Drinker
Feb
16
2016
Athletic Shoe Lawsuits are Off and Running Foley & Lardner LLP
Feb
16
2016
Federal Circuit Affirms Pro-Patent Owner Limits on Patent Exhaustion Neal, Gerber & Eisenberg LLP
Feb
16
2016
PTO Litigation Center Report – February 16, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Feb
16
2016
Brazilian Patent Office and Patent Prosecution Highway Program Michael Best & Friedrich LLP
Feb
16
2016
En Banc Federal Circuit Limits Patent Exhaustion Foley & Lardner LLP
Feb
15
2016
Federal Circuit Holds Foreign Sales Alone Do Not Authorize Use in U.S. Barnes & Thornburg LLP
Feb
15
2016
IPRs And Settlement of Patent Infringement Cases Schwegman, Lundberg & Woessner, P.A.
Feb
13
2016
LG Electronics, Inc. v. ATI Technologies ULC, Granting Request to Expunge Motion for Observation IPR2015-00325 Faegre Drinker
Feb
12
2016
Qualtrics, LLC v. OpinionLab, Inc - Denying Institution of CBM Review Because Claims Not Directed to Financial Product or Service CBM2015-00164 Faegre Drinker
Feb
12
2016
I Prevailed, Now Give Me My Attorneys’ Fees Hunton Andrews Kurth
Feb
12
2016
Copyright Protection in Canada for Artists Dickinson Wright PLLC
Feb
12
2016
Maxlinear, Inc. v. Cresta Technology Corporation - Granting Motion to Compel Routine Discovery Cited in Patent Owner Response IPR2015-00592; IPR2015-00594 Faegre Drinker
Feb
12
2016
PTO Litigation Center Report – February 12, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Feb
12
2016
International Business Machines Corp v. Intellectual Ventures II LLC - Order Regarding Obligation of Party to Make Third-Party Declarant Available for Cross-Examination IPR2015-01322 Faegre Drinker
Feb
11
2016
Federal Circuit Partially Relaxes IdleFree Requirements for Amendments During IPR Foley & Lardner LLP
Feb
11
2016
FDA Panel Shows Strong Support for Remicade Biosimilar Foley & Lardner LLP
Feb
11
2016
Federal Circuit Reinforces PTAB’s Authority to Institute Trial on Selected Claims in Synopsis v. Mentor Graphics Appeal Schwegman, Lundberg & Woessner, P.A.
Feb
11
2016
PTO Litigation Center Report – February 11, 2016 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Feb
11
2016
Remicade Biosimilar Closer To Approval, But Patent Dance Goes On Foley & Lardner LLP
Feb
10
2016
Positive FDA Advisory Committee Vote for First Monoclonal Antibody Biosimilar – But Will Patent Dispute Delay Launch? Mintz
Feb
10
2016
Unified Patents v. Dragon Intellectual Property: Final Written Decision Finding Claims Unpatentable IPR2014-01252 Faegre Drinker
Feb
10
2016
First Monoclonal Antibody Biosimilar in U.S. Gets One Step Closer to FDA Approval Mintz
Feb
10
2016
PTAB Institutes Trial On Previously Challenged Cabilly Patent Foley & Lardner LLP
Feb
10
2016
Mylan Pharmaceuticals and Amneal Pharm v. Yeda Research & Development: Motion to Submit Supplemental Information Was Granted For Public Documents But Denied For Confidential Documents IPR2015-00643, 644, 830 Faegre Drinker
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins